Hot Pursuit     15-Mar-25
Zydus Life’s Gujarat facility clears USFDA inspection with zero observations
Zydus Lifesciences has announced that the US Food and Drug Administration (USFDA) conducted a surveillance inspection at the company’s Active Pharmaceutical Ingredient (API) Unit 1, located in Ankleshwar, Gujarat.

The said inspection was conducted from 10 March to 14 March 2025 and concluded with zero observations from the regulatory body.

The official announcement was made on 14 March 2025.

Zydus Lifesciences is a discovery-driven, global life sciences company that discovers, develops, manufactures, and markets a broad range of healthcare therapies.

The company reported a 29.62% jump in consolidated net profit of Rs 1,023.5 crore in Q3 FY25 compared with Rs 789.6 crore in Q3 FY24. Revenue from operations increased 16.96% YoY to Rs 5,269.1 crore during the quarter.

Shares of Zydus Lifesciences fell 0.73% to end at Rs 882.55 on Thursday, 13 March 2025.

Previous News
  Market opens on firm note; breadth strong
 ( Market Commentary - Mid-Session 26-Aug-24   09:35 )
  Zydus Life gets US FDA nod for UTI treatment drug Methenamine
 ( Hot Pursuit - 12-Mar-25   13:32 )
  Zydus Lifesciences receives USFDA approval for Methenamine Hippurate Tablets
 ( Corporate News - 12-Mar-25   12:59 )
  Zydus Life gets USFDA nod for Zituvimet XR tablets
 ( Hot Pursuit - 19-Jul-24   11:53 )
  Zydus receives USFDA approval for Zituvimet™ XR tablets
 ( Corporate News - 19-Jul-24   13:58 )
  Stock Alert: Zydus Lifesciences, Dr Reddy’s Lab, Shyam Metalics and Energy, KEC International
 ( Market Commentary - Stock Alert 26-Aug-24   08:31 )
  Indices trade near flat line; Media shares rally
 ( Market Commentary - Mid-Session 18-May-24   10:32 )
  Zydus Life jumps on USFDA nod for BP lowering drug
 ( Hot Pursuit - 04-Jul-24   16:28 )
  Zydus Lifesciences consolidated net profit rises 29.62% in the December 2024 quarter
 ( Results - Announcements 05-Feb-25   12:59 )
  Zydus Lifesciences Ltd slips for fifth straight session
 ( Hot Pursuit - 30-May-24   13:35 )
  Zydus Lifesciences consolidated net profit rises 53.24% in the September 2023 quarter
 ( Results - Announcements 07-Nov-23   12:50 )
Other Stories
  Indowind Energy Ltd leads gainers in 'B' group
  22-Apr-25   12:15
  Alok Industries Ltd leads gainers in 'A' group
  22-Apr-25   12:00
  Indag Rubber slides as Q4 PAT fall 66% YoY to Rs 1 cr
  22-Apr-25   11:55
  Mazagon Dock Shipbuilders appoints Capt (retd) Jagmohan as chairman & MD
  22-Apr-25   11:43
  Coal India Inks Rs 16,500-cr MoU with DVC in Jharkhand
  22-Apr-25   11:41
  Metal stocks shine as Govt slaps safeguard duty on steel imports
  22-Apr-25   11:41
  Tata Communications gains after concluding issue of CPs amounting to Rs 500 crore
  22-Apr-25   11:20
  Tata Investment slides as Q4 PAT tumbles 38% to Rs 38 crore; declares dividend of Rs 27/sh
  22-Apr-25   11:17
  Rajratan Global Wire hits the roof after Q4 PAT gains 63% QoQ to Rs 15.20 cr
  22-Apr-25   11:17
  Aditya Birla Money hits the floor after Q4 PAT slumps 43% YoY to Rs 9 cr
  22-Apr-25   11:07
Back Top